Home Conference Coverage ASH Focus on GVHD for Pharmacists

ASH Focus on GVHD for Pharmacists

Itacitinib Plus Corticosteroids for Chronic GVHD

PTCy, Abatacept, and Tacrolimus for GVHD Prophylaxis

Baricitinib Plus Standard GVHD Prophylaxis: Phase 1 Results

The Lasting Impact of Surviving Severe aGVHD

Impact of Ruxolitinib Initiation Timing

Pilot Data on Fecal Microbiotherapy for Acute GI GVHD

PRMT5 Identified as Potential GVHD Treatment Target

Ruxolitinib With Corticosteroids in Pediatric GVHD

Belumosudil Significantly Affects IST Serum Concentrations

Adding Itacitinib to Conventional GVHD Prophylaxis

Load more
Subscribe to RSS